The 3' Untranslated Region of the Cyclin B mRNA Is Not Sufficient to Enhance the Synthesis of Cyclin B during a Mitotic Block in Human Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Schnerch, Dominik ^a,b   Follo, Marie ^a   Felthaus, Julia ^a   Engelhardt, Monika ^a   Wäsch, Ralph ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CYCLIN B1; MESSENGER RNA; NOCODAZOLE; PACLITAXEL;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CELL LINE; CELL STRAIN U2OS; CELLULAR PARAMETERS; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMAGING AND DISPLAY; LIVE CELL IMAGING; MITOSIS INHIBITION; MITOTIC SLIPPAGE; PIGMENT CELL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; CHROMOSOMES, HUMAN; CYCLIN B; GENES, REPORTER; HUMANS; KINETICS; MICE; MICROTUBULES; MITOSIS; PACLITAXEL; PROTEOLYSIS; RNA, MESSENGER;

EID: 84884144369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074379     Document Type: Article

References (26)

1. Peters JM, (2006) The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 7: 644-656. doi:10.1038/nrm1988. PubMed: 16896351.
2. Pines J, (2011) Cubism and the cell cycle: the many faces of the APC/C. Nat Rev Mol Cell Biol 12: 427-438. doi:10.1038/nrm3132. PubMed: 21633387.
3. Kops GJ, Shah JV, (2012) Connecting up and clearing out: how kinetochore attachment silences the spindle assembly checkpoint. Chromosoma 121: 509-525. doi:10.1007/s00412-012-0378-5. PubMed: 22782189.
4. Foley EA, Kapoor TM, (2013) Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat Rev Mol Cell Biol 14: 25-37. PubMed: 23258294.
5. Brito DA, Rieder CL, (2006) Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 16: 1194-1200. doi:10.1016/j.cub.2006.04.043. PubMed: 16782009.
6. Gascoigne KE, Taylor SS, (2008) Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111-122. doi:10.1016/j.ccr.2008.07.002. PubMed: 18656424.
7. Schnerch D, Follo M, Krohs J, Felthaus J, Engelhardt M, et al. (2012) Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populations. Cell Cycle 11: 310-321. doi:10.4161/cc.11.2.18737. PubMed: 22214763.
8. Huang HC, Mitchison TJ, Shi J, (2010) Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest. PLOS ONE 5: e15724. doi:10.1371/journal.pone.0015724. PubMed: 21203573.
9. Wäsch R, (2011) Targeting mitotic exit for cancer treatment. Expert Opin Ther Targets 15: 785-788. doi:10.1517/14728222.2011.577420. PubMed: 21476883.
10. Chan KS, Koh CG, Li HY, (2012) Mitosis-targeted anti-cancer therapies: where they stand. Cell Death. Drosophila Inf Serv 3: e411.
11. Wolf F, Wandke C, Isenberg N, Geley S, (2006) Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. EMBO J 25: 2802-2813. doi:10.1038/sj.emboj.7601163. PubMed: 16724106.
12. Wäsch R, Cross FR, (2002) APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit. Nature 418: 556-562. doi:10.1038/nature00856. PubMed: 12152084.
13. Sciortino S, Gurtner A, Manni I, Fontemaggi G, Dey A, et al. (2001) The cyclin B1 gene is actively transcribed during mitosis in HeLa cells. EMBO Rep 2: 1018-1023. doi:10.1093/embo-reports/kve223. PubMed: 11606417.
14. Malureanu L, Jeganathan KB, Jin F, Baker DJ, van Ree JH, et al. (2010) Cdc20 hypomorphic mice fail to counteract de novo synthesis of cyclin B1 in mitosis. J Cell Biol 191: 313-329. doi:10.1083/jcb.201003090. PubMed: 20956380.
15. Mena AL, Lam EW, Chatterjee S, (2010) Sustained spindle-assembly checkpoint response requires de novo transcription and translation of cyclin B1. PLOS ONE 5([MedlinePgn:]) PubMed: 20927403.
16. Groisman I, Jung MY, Sarkissian M, Cao Q, Richter JD, (2002) Translational control of the embryonic cell cycle. Cell 109: 473-483. doi:10.1016/S0092-8674(02)00733-X. PubMed: 12086604.
17. Le Breton M, Cormier P, Bellé R, Mulner-Lorillon O, Morales J, (2005) Translational control during mitosis. Biochimie 87: 805-811. doi:10.1016/j.biochi.2005.04.014. PubMed: 15951098.
18. Russo AJ, Magro PG, Hu Z, Li WW, Peters R, et al. (2006) E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents. Cancer Res 66: 7253-7260. doi:10.1158/0008-5472.CAN-05-3725. PubMed: 16849574.
19. Schnerch D, Schmidts A, Follo M, Udi J, Felthaus J, et al. (2013) BubR1 is frequently repressed in acute myeloblastic leukemia and its re-expression sensitizes to antimitotic therapy. Haematologica: epub, June 28, 2013. doi:10.3324/haematol.2013.087452. PubMed: 23812934.
20. de Moor CH, Richter JD, (1999) Cytoplasmic polyadenylation elements mediate masking and unmasking of cyclin B1 mRNA. EMBO J 18: 2294-2303. doi:10.1093/emboj/18.8.2294. PubMed: 10205182.
21. Weaver BA, Cleveland DW, (2005) Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 8: 7-12. doi:10.1016/j.ccr.2005.06.011. PubMed: 16023594.
22. Schnerch D, Follo M, Felthaus J, Engelhardt M, Wäsch R, (2012) Studying proteolysis of cyclin B at the single cell level in whole cell populations. J Vis Exp: pp. e4239. PubMed: 23007658.
23. Engelbert D, Schnerch D, Baumgarten A, Wäsch R, (2008) The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells. Oncogene 27: 907-917. doi:10.1038/sj.onc.1210703. PubMed: 17700535.
24. Huang HC, Shi J, Orth JD, Mitchison TJ, (2009) Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16: 347-358. doi:10.1016/j.ccr.2009.08.020. PubMed: 19800579.
25. Manchado E, Guillamot M, de Cárcer G, Eguren M, Trickey M, et al. (2010) Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55alpha,delta phosphatase. Cancer Cell 18: 641-654. doi:10.1016/j.ccr.2010.10.028. PubMed: 21156286.
26. Zeng X, Sigoillot F, Gaur S, Choi S, Pfaff KL, et al. (2010) Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell 18: 382-395. doi:10.1016/j.ccr.2010.08.010. PubMed: 20951947.